These findings have also been corroborated by in vivo studies, where the induction of renal cell carcinoma in mice through MYC oncogene activation resulted in increased ASCT2 and SNAT1 but decreased SNAT2 mRNA levels [27]. The gene discussed is MYC; the disease is hereditary clear cell renal cell carcinoma.